Intellia Therapeutics Inc buy Chardan Capital
Start price
07.08.23
/
50%
€35.98
Target price
07.08.24
€97.28
Performance (%)
-34.27%
Price
22:26
€23.65
Summary
This prediction is currently active. Massive losses of -34.27% have been the result for the BUY prediction by Chardan_Capital. This prediction currently runs until 07.08.24. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 6.773% | 6.773% |
| iShares Core DAX® | 0.443% | 0.771% |
| iShares Nasdaq 100 | -0.150% | 4.094% |
| iShares Nikkei 225® | 2.566% | 4.202% |
| iShares S&P 500 | 0.479% | 2.881% |
Comments by Chardan_Capital for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $107.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat